Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT

In spite of the usual combination form of methotrexate (MTX)/mitoxantrone (MIT) and various complex combination regimens of MTX/MIT with other anticancer drugs, the survival period, cure rate, and systemic toxicity still need to be improved. For this purpose, a nanostructured amino group-modified me...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ning, Zhao, Ming, Wang, Yuji, Hu, Xi, Wu, Jianhui, Jiang, Xueyun, Li, Shan, Cui, Chunying, Peng, Shiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012610/
https://www.ncbi.nlm.nih.gov/pubmed/27621591
http://dx.doi.org/10.2147/DDDT.S113804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012610/
https://www.ncbi.nlm.nih.gov/pubmed/27621591
http://dx.doi.org/10.2147/DDDT.S113804

Ejemplares similares